Mental Health Clinics in Merchantville, NJ Accepting Medicare
6 Mental Health Clinics found. Showing 1 - 6
 Children's Continuum Of Care Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 177 S Centre St, Suite B, Merchantville, NJ 08109 Phone: 856-661-1100 Fax: 856-661-0910 |
Craig Nussbaum Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 128 Ivins Ave, Merchantville, NJ 08109 Phone: 609-605-2847 |
Wellspring Center Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 18c S Centre St, Merchantville, NJ 08109 Phone: 856-662-1660 Fax: 856-662-6110 |
Joyful Living Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 27 E Chestnut Ave, Merchantville, NJ 08109 Phone: 856-296-9323 Fax: 856-317-9059 |
Instrumental Change Llc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 210 E Maple Ave, D3, Merchantville, NJ 08109 Phone: 609-313-4341 |
Merchantville Counseling Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 109 W Maple Ave, Merchantville, NJ 08109 Phone: 856-661-0324 |
News Archive
Drug addiction expert uncovers molecular mechanisms that contribute to addiction resistance
Growing up in West Virginia, Jill Turner saw firsthand the kind of havoc that drug addiction can wreak. "I had a lot of friends who had very promising lives and promising careers ahead of them," the assistant professor in the South Carolina College of Pharmacy says, "but they ended up either overdosing or going to jail for drug-related stuff. It's one of the reasons I went into drug addiction research."
Clarient adopts QIAGEN's therascreen KRAS test to diagnose colorectal cancer
QIAGEN N.V. today announced that Clarient - a GE Healthcare Company and leading provider of cancer laboratory testing services in the United States - has adopted the use of the therascreen KRAS RGQ PCR Kit (therascreen KRAS test) as a companion diagnostic to guide the use of Erbitux (cetuximab) as a treatment in patients with metastatic colorectal cancer.
Multiple study data on Agendia's MammaPrint, BluePrint, and ColoPrint assays to be presented at 2010 ASCO
Agendia, a world leader in molecular cancer diagnostics, today announced that researchers from Agendia and leading academic centers in the U.S. and Europe will present data from multiple studies concerning Agendia's assays MammaPrint(R), BluePrint(TM), and ColoPrint(TM) at the American Society of Clinical Oncology Annual Meeting, June 4 - 8, 2010, at McCormick Place in Chicago. MammaPrint, the company's lead product, is the only FDA-cleared breast cancer recurrence test.
Funds to support study of telephone-based treatment program for lung cancer patients
An assistant professor of psychology in the School of Science at IUPUI will apply nearly $1 million in recently approved grants to study how a telephone-based treatment process can help ease stress and anxiety issues experienced by advanced-stage lung cancer patients and the family members who care for them.
Patients with muscular dystrophy mount immune response to dystophin protein prior to gene therapy: Study
A clinical trial designed to replace the genetic defect causing the most common form of muscular dystrophy has uncovered an unexpected aspect of the disease. The trial, based on therapy designed by scientists at the University of North Carolina at Chapel Hill School of Medicine, showed that some patients mount an immune response to the dystrophin protein even before they have received the gene therapy.
› Verified 7 days ago